Cargando…
Effects of Purinergic Receptor Deletion or Pharmacologic Modulation on Pulmonary Inflammation in Mice
[Image: see text] COVID-19 disease is associated with progressive accumulation of SARS-CoV-2-specific mRNA, which is recognized by innate immune receptors, such as TLR3. This in turn leads to dysregulated production of multiple cytokines, including IL-6, IFN-γ, CXCL1, and TNF-α. Excessive production...
Autores principales: | Whitehead, Gregory S., Karcz, Tadeusz P., Tosh, Dilip K., Jung, Young-Hwan, Wen, Zhiwei, Campbell, Ryan G., Gopinatth, Varun, Gao, Zhan-Guo, Jacobson, Kenneth A., Cook, Donald N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578140/ https://www.ncbi.nlm.nih.gov/pubmed/36268115 http://dx.doi.org/10.1021/acsptsci.2c00128 |
Ejemplares similares
-
Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019) -
Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023) -
Purinergic Signaling in Mast Cell Degranulation and Asthma
por: Gao, Zhan-Guo, et al.
Publicado: (2017) -
Purinergic Signaling in Liver Pathophysiology
por: Jain, Shanu, et al.
Publicado: (2021) -
Purinergic Receptors in Ocular Inflammation
por: Guzman-Aranguez, Ana, et al.
Publicado: (2014)